Antiviral Immunoglobulin Market Report

Global and Region Antiviral Immunoglobulin Market Demand & Opportunity Outlook 2024

  • POSTDATE：Jan 16, 2024
  • PAGES：148
  • REPORT CODE：GMM1861430
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Antiviral Immunoglobulin market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Antiviral Immunoglobulinmarket, defines the market attractiveness level of Antiviral Immunoglobulin market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Antiviral Immunoglobulin industry, describes the types of Antiviral Immunoglobulin market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antiviral Immunoglobulin market and the development prospects and opportunities of Antiviral Immunoglobulin industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antiviral Immunoglobulin market in Chapter 13.

    By Player:

    • AstraZeneca Plc

    • Bayer AG

    • CSL Behring

    • Sanofi Pasteur SA

    • Cangene Corporation

    • Baxter International Inc

    • Talecris Biotherapeutics, Inc

    • Biota Holdings Limited

    By Type:

    • Intramuscular Injections

    • Intravenous

    • Subcutaneous

    By End-User:

    • Drug Stores

    • Retail Pharmacies

    • Hospital pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Antiviral Immunoglobulin Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Antiviral Immunoglobulin Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Antiviral Immunoglobulin Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Antiviral Immunoglobulin Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Antiviral Immunoglobulin Market Analysis and Outlook to 2022

    • 7.1 Global Antiviral Immunoglobulin Consumption (2017-2022)

    • 7.2 United States Antiviral Immunoglobulin Consumption (2017-2022)

    • 7.3 Europe Antiviral Immunoglobulin Consumption (2017-2022)

    • 7.4 China Antiviral Immunoglobulin Consumption (2017-2022)

    • 7.5 Japan Antiviral Immunoglobulin Consumption (2017-2022)

    • 7.6 India Antiviral Immunoglobulin Consumption (2017-2022)

    • 7.7 South Korea Antiviral Immunoglobulin Consumption (2017-2022)

    8 Region and Country-wise Antiviral Immunoglobulin Market Analysis and Outlook to 2028

    • 8.1 Global Antiviral Immunoglobulin Consumption Forecast (2022-2028)

    • 8.2 United States Antiviral Immunoglobulin Consumption Forecast (2022-2028)

    • 8.3 Europe Antiviral Immunoglobulin Consumption Forecast (2022-2028)

    • 8.4 China Antiviral Immunoglobulin Consumption Forecast (2022-2028)

    • 8.5 Japan Antiviral Immunoglobulin Consumption Forecast (2022-2028)

    • 8.6 India Antiviral Immunoglobulin Consumption Forecast (2022-2028)

    • 8.7 South Korea Antiviral Immunoglobulin Consumption Forecast (2022-2028)

    9 Global Antiviral Immunoglobulin Market Outlook by Types and Applications to 2022

    • 9.1 Global Antiviral Immunoglobulin Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Intramuscular Injections Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Intravenous Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Subcutaneous Consumption and Growth Rate (2017-2022)

    • 9.2 Global Antiviral Immunoglobulin Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Drug Stores Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Hospital pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Antiviral Immunoglobulin Market Outlook by Types and Applications to 2028

    • 10.1 Global Antiviral Immunoglobulin Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Intramuscular Injections Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Intravenous Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Antiviral Immunoglobulin Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Hospital pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Antiviral Immunoglobulin Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Antiviral Immunoglobulin Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Antiviral Immunoglobulin Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Antiviral Immunoglobulin Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Antiviral Immunoglobulin Market Competitive Analysis

    • 14.1 AstraZeneca Plc

      • 14.1.1 AstraZeneca Plc Company Details

      • 14.1.2 AstraZeneca Plc Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AstraZeneca Plc Antiviral Immunoglobulin Product and Service

    • 14.2 Bayer AG

      • 14.2.1 Bayer AG Company Details

      • 14.2.2 Bayer AG Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bayer AG Antiviral Immunoglobulin Product and Service

    • 14.3 CSL Behring

      • 14.3.1 CSL Behring Company Details

      • 14.3.2 CSL Behring Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 CSL Behring Antiviral Immunoglobulin Product and Service

    • 14.4 Sanofi Pasteur SA

      • 14.4.1 Sanofi Pasteur SA Company Details

      • 14.4.2 Sanofi Pasteur SA Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sanofi Pasteur SA Antiviral Immunoglobulin Product and Service

    • 14.5 Cangene Corporation

      • 14.5.1 Cangene Corporation Company Details

      • 14.5.2 Cangene Corporation Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Cangene Corporation Antiviral Immunoglobulin Product and Service

    • 14.6 Baxter International Inc

      • 14.6.1 Baxter International Inc Company Details

      • 14.6.2 Baxter International Inc Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Baxter International Inc Antiviral Immunoglobulin Product and Service

    • 14.7 Talecris Biotherapeutics, Inc

      • 14.7.1 Talecris Biotherapeutics, Inc Company Details

      • 14.7.2 Talecris Biotherapeutics, Inc Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Talecris Biotherapeutics, Inc Antiviral Immunoglobulin Product and Service

    • 14.8 Biota Holdings Limited

      • 14.8.1 Biota Holdings Limited Company Details

      • 14.8.2 Biota Holdings Limited Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Biota Holdings Limited Antiviral Immunoglobulin Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Antiviral Immunoglobulin

    • Figure Antiviral Immunoglobulin Picture

    • Table Global Antiviral Immunoglobulin Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Antiviral Immunoglobulin Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Antiviral Immunoglobulin Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Antiviral Immunoglobulin Consumption by Country (2017-2022)

    • Figure United States Antiviral Immunoglobulin Consumption and Growth Rate (2017-2022)

    • Table Europe Antiviral Immunoglobulin Consumption and Growth Rate (2017-2022)

    • Figure China Antiviral Immunoglobulin Consumption and Growth Rate (2017-2022)

    • Figure Japan Antiviral Immunoglobulin Consumption and Growth Rate (2017-2022)

    • Figure India Antiviral Immunoglobulin Consumption and Growth Rate (2017-2022)

    • Figure South Korea Antiviral Immunoglobulin Consumption and Growth Rate (2017-2022)

    • Figure Global Antiviral Immunoglobulin Consumption Forecast by Country (2022-2028)

    • Figure United States Antiviral Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Antiviral Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Antiviral Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Antiviral Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Antiviral Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Antiviral Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intramuscular Injections Consumption and Growth Rate (2017-2022)

    • Figure Global Intravenous Consumption and Growth Rate (2017-2022)

    • Figure Global Subcutaneous Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Stores Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Intramuscular Injections Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intravenous Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Antiviral Immunoglobulin Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Antiviral Immunoglobulin Export by Region (Top 5 Countries) (2017-2028)

    • Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Plc Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Plc Antiviral Immunoglobulin Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Antiviral Immunoglobulin Product and Service

    • Table CSL Behring (Foundation Year, Company Profile and etc.)

    • Table CSL Behring Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Behring Antiviral Immunoglobulin Product and Service

    • Table Sanofi Pasteur SA (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur SA Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur SA Antiviral Immunoglobulin Product and Service

    • Table Cangene Corporation (Foundation Year, Company Profile and etc.)

    • Table Cangene Corporation Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cangene Corporation Antiviral Immunoglobulin Product and Service

    • Table Baxter International Inc (Foundation Year, Company Profile and etc.)

    • Table Baxter International Inc Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter International Inc Antiviral Immunoglobulin Product and Service

    • Table Talecris Biotherapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Talecris Biotherapeutics, Inc Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Talecris Biotherapeutics, Inc Antiviral Immunoglobulin Product and Service

    • Table Biota Holdings Limited (Foundation Year, Company Profile and etc.)

    • Table Biota Holdings Limited Antiviral Immunoglobulin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biota Holdings Limited Antiviral Immunoglobulin Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US